Add to ORKG药物性肝损伤(DILI),是药物不良反应的主要类型之一,同时保肝药在临床上广泛用于肝脏损害的预防和治疗.保肝药对DILI的治疗作用有多种不同的途径和机制,治疗效果也不尽相同.本文根据近年来国内外的相关研究,详细介绍了保肝药治疗DILI的进展.中国科技核心期刊(ISTIC)中国科学引文数据库(CSCD)2231-2362
International audienceDrug induced liver injury (DILI) is a major cause of acute liver failure (ALF)...
In recent years, the number of drug-induced liver injury (DILI) cases is increasing year by year due...
目的:分析致肝损害的药物种类、临床表现及预后,探讨预防措施.方法:采取回顾性分析的方法,对本院2000年1月至2003年12月临床各科药物性肝损害的报表111份进行统计分析.结果:111例药物性肝损害...
中毒性肝损害在临床上十分常见,发病率仅次于病毒性肝炎.本文主要从肝脏对药物(毒物)的代谢、肝损害基本要素以及中毒性肝损害的发病机制研究等方面进行综述,以便于今后临床科研工作.北京市自然科学基金中国科技...
目的:观察保肝药治疗肝硬化患者肝损害的疗效.方法:139例肝硬化患者分为:(1)肝太乐组:30例,600 mg/d;(2)甘利欣组:34例,30 ml/d;(3)TAD(还原型谷胱甘肽)组:37例, ...
Background: Drug-induced liver injury (DILI) is a common and serious adverse drug reaction with insu...
Drug-induced liver injury (DILI) is a major cause of late-stage clinical drug attrition, market with...
No multi-national prospective study of drug-induced liver injury (DILI) has originated in Europe. Th...
BACKGROUND & AIMS No multi-national prospective study of drug-induced liver injury (DILI) has ori...
BACKGROUND: Drug-induced Liver Injury (DILI) is an important cause of acute liver failure cases in t...
We investigated clinical features, therapy, and outcomes of patients hospitalized for drug-induced l...
No multi-national prospective study of drug-induced liver injury (DILI) has originated in Europe. Th...
International audienceDrug induced liver injury (DILI) is a major cause of acute liver failure (ALF)...
Drug-induced liver injury (DILI) is one of the most common and serious adverse drug reactions and ca...
International audienceDrug induced liver injury (DILI) is a major cause of acute liver failure (ALF)...
International audienceDrug induced liver injury (DILI) is a major cause of acute liver failure (ALF)...
In recent years, the number of drug-induced liver injury (DILI) cases is increasing year by year due...
目的:分析致肝损害的药物种类、临床表现及预后,探讨预防措施.方法:采取回顾性分析的方法,对本院2000年1月至2003年12月临床各科药物性肝损害的报表111份进行统计分析.结果:111例药物性肝损害...
中毒性肝损害在临床上十分常见,发病率仅次于病毒性肝炎.本文主要从肝脏对药物(毒物)的代谢、肝损害基本要素以及中毒性肝损害的发病机制研究等方面进行综述,以便于今后临床科研工作.北京市自然科学基金中国科技...
目的:观察保肝药治疗肝硬化患者肝损害的疗效.方法:139例肝硬化患者分为:(1)肝太乐组:30例,600 mg/d;(2)甘利欣组:34例,30 ml/d;(3)TAD(还原型谷胱甘肽)组:37例, ...
Background: Drug-induced liver injury (DILI) is a common and serious adverse drug reaction with insu...
Drug-induced liver injury (DILI) is a major cause of late-stage clinical drug attrition, market with...
No multi-national prospective study of drug-induced liver injury (DILI) has originated in Europe. Th...
BACKGROUND & AIMS No multi-national prospective study of drug-induced liver injury (DILI) has ori...
BACKGROUND: Drug-induced Liver Injury (DILI) is an important cause of acute liver failure cases in t...
We investigated clinical features, therapy, and outcomes of patients hospitalized for drug-induced l...
No multi-national prospective study of drug-induced liver injury (DILI) has originated in Europe. Th...
International audienceDrug induced liver injury (DILI) is a major cause of acute liver failure (ALF)...
Drug-induced liver injury (DILI) is one of the most common and serious adverse drug reactions and ca...
International audienceDrug induced liver injury (DILI) is a major cause of acute liver failure (ALF)...
International audienceDrug induced liver injury (DILI) is a major cause of acute liver failure (ALF)...
In recent years, the number of drug-induced liver injury (DILI) cases is increasing year by year due...
目的:分析致肝损害的药物种类、临床表现及预后,探讨预防措施.方法:采取回顾性分析的方法,对本院2000年1月至2003年12月临床各科药物性肝损害的报表111份进行统计分析.结果:111例药物性肝损害...